Cdkn2a
CDKN2A is a gene that encodes for two distinct tumor suppressor proteins, p16INK4a and p14ARF, which play important roles in cell cycle regulation and tumor suppression. The p16INK4a protein inhibits the activity of cyclin-dependent kinases CDK4 and CDK6, thereby preventing the phosphorylation of the retinoblastoma protein (Rb) and blocking cell cycle progression. The p14ARF protein, on the other hand, stabilizes the p53 tumor suppressor protein by inhibiting its degradation. This gene is frequently altered or inactivated in a wide variety of cancers, making it an important biomarker and target for cancer research and diagnostics.
Lab products found in correlation
3 protocols using cdkn2a
Western Blot Analysis of Cell Signaling
Immunohistochemical analysis of mouse brains
Primary antibodies used were: H3K27me3 diluted 1:200 (Cell Signaling, #9733), pRB diluted 1:3000 (Cell Signaling, #8516), cC3 diluted 1:400 (Biocare Medical, #CP229C), NeuN diluted 1:10,000 (Millipore, MAB377), Myogenin (MYOG) diluted 1:500 (Abcam, ab124800), SMYD1 diluted 1:100 (ThermoFisher, PA5-84544), and CDKN2A diluted 1:500 (Abcam, ab241543). Stained images were counterstained with DAPI.
Protein Expression Analysis in Graft Tissues
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!